About iGan Partners
iGan Partners is a venture capital firm founded in 2011. It is primarily based out of Toronto, Canada. As of May 2026, iGan Partners is an active investor, having invested in 36 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in Canada based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to HealthTech and Life Sciences. Most recently it participated in the $***** Seed round of Adenocyte Overall, iGan Partners portfolio has seen 8 acquisitions including key companies like Think Research, Quandl and Akira. A lot of funds co-invest with iGan Partners, with names like MaRS IAF sharing a substantial percentage of its portfolio. iGan Partners has team of 30 people including 6 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio Acquisitions
Deals in last 12 months
iGan Partners' List of Top Investments
iGan Partners has a portfolio of 36 companies. Their most notable investments are in Exact Imaging and Exact Imaging.Their portfolio spans across Canada, United States, Israel and 2 more locations. They have invested in Enterprise Applications, HealthTech, Life Sciences and 9 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by iGan Partners:Think Research offers SaaS-based point of care management software for clinical decision support. The company has developed decision-making tools for doctors, nurses, and pharmacists. The platform includes comprehensive libraries of evidence-based order sets, a module for medication requisition, eForms, health apps, and analytics, delivered through a secure, cloud-based platform. Products include EntryPoint Platform; Apps which comprise of EntryPoint Platform, Patient Order Sets a COVID-19 tool, Progress Notes, QBPs, Spotlight Analytics, MedRec, eForms, and TxConnect.
Key facts about Think Research
- Founded Year: 2006
- Location: Toronto (Canada)
- Stage: Acquired
- Total Funding till date: $25M
- Employee Count: 125 as on Sep 30, 2026
- Investors: National Bank of Canada, MaRS Discovery District and 10 Others
- Latest Funding Round: Post IPO, Apr 25, 2022, $*****
- Highlight: Acquired
2. Seg Med
Provider of AI-based clinical data management software and services for researchers. The platform allows the sourcing of data and preparing it in a way that can be used by patients, clinicians, and researchers, as well as for artificial intelligence training. Researchers can curate data, access clinical data, use data analysis tools, and more using the platform and services offered by the company.
Key facts about Seg Med
- Founded Year: 2019
- Location: Stanford (United States)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $17.7M
- Employee Count: 48 as on Aug 31, 2026
- Investors: Mighty Capital, Alchemist Accelerator and 17 Others
- Latest Funding Round: Series A, Sep 03, 2024, $*****
- Highlight: Editors' Pick
Flosonics Medical is a developer of non-invasive sensors for the management of critically ill patients, performing continuous monitoring of arterial flow with automatic artery detection. The company develops products for fluid responsiveness detection in the ICU, E.D, and operating room. The company's smart-bandage product, FloPatch, is designed to address the clinical needs of critically ill patients and the physicians, nurses, and paramedics who care for them in the ambulance, emergency department, operating room, and intensive care unit. The patch is disposable and is enabled with ultrasound technology.
Key facts about Flosonics Medical
- Founded Year: 2015
- Location: Greater Sudbury (Canada)
- Stage: Series C
- Total Funding till date: $39M
- Employee Count: 75 as on Sep 30, 2026
- Investors: New Leaf Venture Partners, Graphite Ventures and 15 Others
- Latest Funding Round: Venture Debt, Mar 03, 2025, $*****
- Highlight: Editors' Pick
Exact Imaging has developed a micro-ultrasound based imaging device. The ExactVu system operates at 29MHz waves for higher resolution and is used for imaging prostate cancer and biopsies. The product has an integrated disposable needle biopsy apparatus for visualization and targeting of suspicious small regions. in real-time
Key facts about Exact Imaging
- Founded Year: 2013
- Location: Markham (Canada)
- Stage: Series D
- Total Funding till date: $39.9M
- Employee Count: 47 as on Sep 30, 2026
- Investors: Graphite Ventures, Veddis App and 9 Others
- Latest Funding Round: Series D, Feb 10, 2026, $*****
- Highlight: Editors' Pick
5. MolecuLight
Provider of point of care device for wound assessment. The company's first product, the i:X, is a hand-held fluorescence imaging device for visualizing bacterial presence and distribution in the skin and chronic wounds. i:X launched in 2015. Founded by Dr. Ralph Da Costa.
Key facts about MolecuLight
- Founded Year: 2013
- Location: Toronto (Canada)
- Stage: Series D
- Total Funding till date: $43.2M
- Employee Count: 49 as on May 27, 2025
- Investors: SWK Holdings, MaRS Discovery District and 7 Others
- Latest Funding Round: Series D, Jan 06, 2025, $*****
- Highlight: Editors' Pick
iGan Partners' Year-on-Year Investment Trends
iGan Partners has invested in 36 companies over the last 14 years, with an average of 2 new investments annually in the last 10 years. In 2025, it made 3 investments, while as of May 2026, it has made 2 investments in this year. Its most recent first time investment was in Adenocyte and most recent follow-on round was in Exact Imaging.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 1 | 2 |
2025 | 2 | 1 | 3 |
2024 | 1 | 2 | 3 |
2023 | 0 | 0 | 0 |
2022 | 3 | 2 | 5 |
2021 | 1 | 3 | 4 |
2020 | 0 | 0 | 0 |
2019 | 2 | 2 | 4 |
2018 | 5 | 0 | 5 |
2017 | 1 | 2 | 3 |
iGan Partners' Investments by Stage
iGan Partners has made 17 investments in Seed stage with an average round size of $2.72M and 7 investments in Series A stage with an average round size of $5.87M.Stage of entry | No. of Investments |
|---|---|
Seed | 17 |
Series A | 7 |
Note: We have considered here, only first round of investments
iGan Partners' Investments by Sector
iGan Partners has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, Life Sciences, Vertical SaaS and FinTech. Notably, it has invested in 36 Tech companies, 31 Enterprise (B2B) companies, 25 Software companies and at least 10 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 13 |
HealthTech | 12 |
Life Sciences | 9 |
Vertical SaaS | 5 |
FinTech | 3 |
Others | 11 |
Note: We have considered here, only first round of investments
iGan Partners' Investments by Geography
iGan Partners has made most investments in Canada (15), followed by United States where it has made 6 investments.Country | No. of Investments |
|---|---|
Canada | 15 |
United States | 6 |
Israel | 2 |
United Arab Emirates | 1 |
Note: We have considered here, only first round of investments
iGan Partners' recent investments
iGan Partners has made 2 investments in 2026 so far - Adenocyte and Exact Imaging.Here are the most recent investments by iGan Partners:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 26, 2026 | Israel | Seed | 1655 | - | |
Feb 10, 2026 | Canada | Series D | 6352 | - | |
Aug 09, 2025 | United States | Seed | 5161 | - | |
Jun 05, 2025 | Canada | Seed | 7189 | ||
May 29, 2025 | United States | Seed | 8388 | - |
Acquired companies in iGan Partners' Portfolio
8 companies from iGan Partners' portfolio have been acquired. The most recent acquisition was Think Research in Feb 2024 by Beedie Capital for $*****.Here are iGan Partners' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 16, 2024 | - | - | 5206 | |
Jan 04, 2021 | - | - | 8690 | |
Jul 24, 2019 | - | - | 1422 | |
Jul 20, 2019 | - | - | 9636 | |
May 09, 2019 | Jul 09, 2018 | Seed | 1759 |
Team profile of iGan Partners
iGan Partners has a team of 30 members including 6 Partners and 1 Venture Partner located in Canada and Mexico. iGan Partners' team sits on the board of 1 company.Here is a list of top team members in iGan Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Toronto | - | - | |
Partner | Toronto | - | ||
Partner | Toronto | - | - | |
Partner | Mexico | - | - | |
Partner | Toronto | - | ||
Partner | - | - | - | |
Venture Partner | Toronto |
Co-investors of iGan Partners
Over the past 14 years, 110 investors have co-invested in iGan Partners's portfolio companies. This includes funds and angels.
- Invested before iGan Partners: Techstars, Y Combinator and 17 others have invested in rounds before iGan Partners. There are 2 companies where Techstars has invested before iGan Partners and 1 company where Y Combinator has invested before iGan Partners.
- Top Co-investors of iGan Partners: 38 investors entered a company along with iGan Partners. These include investors like MaRS IAF (2 companies).
- Invested after iGan Partners: A total of 53 investors have invested in iGan Partners's portfolio after their investments. Top Investors include MaRS IAF (2 companies), BDC (2 companies) and Flashpoint (1 company).
Recent News related to iGan Partners
•
iGan Partners Portfolio Update: Momentum Across Medtech and Health DataCNW•Sep 11, 2026•iGan Partners
•
iGan Partners Leads $10M Investment in Adenocyte to Advance Early Pancreatic Cancer DetectionCNW•May 26, 2026•iGan Partners
•
iGan Partners Leads $10 Million Financing of Exact ImagingPR Newswire•Feb 10, 2026•Exact Imaging, iGan Partners
•
iGan invests in surgeon-founded tech firm DOCSI to enhance perioperative supply chainHospital Management•Aug 08, 2025•DOCSI, iGan Partners
•
Cosm Medical Secures Seed+ Funding Round Led by iGan PartnersFinSMEs•Jun 05, 2025•Spring Impact Capital, COSM, iGan Partners
•
•
Segmed: Medical Imaging Data Company Raises $10.4 Million (Series A)Pulse 2.0•Sep 12, 2024•Seg Med, iGan Partners, Advocate Health, Castellan and 8 others
•
iGan Partners and Medical Alley Announce Strategic Alliance for Medtech AdvancementCNW•Sep 10, 2024•iGan Partners, Medicalalley
•
Advocate Health leads $10.5M in funding for data startupBecker's Hospital Review•Sep 04, 2024•Advocate Health, iGan Partners, Fox Chase Cancer Center
•
Segmed Secures $10.4 Million Series A Funding, Led by iGan Partners and Advocate HealthPR Newswire•Sep 03, 2024•Seg Med, iGan Partners, Advocate Health, Castellan and 8 others
